
pmid: 12667466
Previous studies in the literature have resulted in conflicting reports on the potential neurotoxicity of the beta-cleaved Alzheimer's disease C-terminal fragment (beta-CTF) of beta-amyloid precursor protein in vivo. To readdress this question by rigorous quantitative methods, we analyzed transgenic mice expressing human beta-CTF with the I45F mutation (SPA4CT) under control of the prion protein promoter by stereological techniques. The transgene was expressed in hippocampus and cortex in large pyramidal neurons and in dentate gyrus granule cells. Proteolytic processing of beta-CTF released Abeta. However, most of it remained uncleaved. Neurodegeneration was evaluated by investigating the numbers of hippocampal pyramidal and granule neurons, as well as the number of synaptophysin-immunopositive presynaptic boutons in the hippocampus of 15-month-old SPA4CT mice with design-based stereological techniques. The analyses showed that a fourfold higher expression of the transgene compared to murine APP levels had no effect on the numbers of both neurons and synaptophysin-immunopositive presynaptic boutons. These data implicate that expression of beta-CTF per se is not neurotoxic, and that other mechanisms are responsible for the neurotoxic events in Alzheimer's disease brain.
Protein Structure, Mutation/genetics, Transgenes/genetics, Amyloid beta-Peptides/biosynthesis, Stereology, Hippocampus/metabolism, Presynaptic Terminals, Synaptophysin, Neurosciences. Biological psychiatry. Neuropsychiatry, Mice, Transgenic, Synaptophysin/metabolism, Cell Death/genetics, Tertiary/genetics, Gene Expression Regulation/genetics, Hippocampus, Transgenic, Nerve Degeneration/genetics, Amyloid beta-Protein Precursor, Mice, Alzheimer Disease, SPA4CT, Animals, Transgenes, Peptide Fragments/genetics, Neurodegeneration, Alzheimer Disease/genetics, Amyloid beta-Peptides, Cell Death, Animal, Intraneuronal Aβ, Amyloid beta-Protein Precursor/metabolism, Immunohistochemistry, Peptide Fragments, Protein Structure, Tertiary, Presynaptic Terminals/metabolism, Disease Models, Animal, Gene Expression Regulation, Disease Models, Mutation, Nerve Degeneration, RC321-571
Protein Structure, Mutation/genetics, Transgenes/genetics, Amyloid beta-Peptides/biosynthesis, Stereology, Hippocampus/metabolism, Presynaptic Terminals, Synaptophysin, Neurosciences. Biological psychiatry. Neuropsychiatry, Mice, Transgenic, Synaptophysin/metabolism, Cell Death/genetics, Tertiary/genetics, Gene Expression Regulation/genetics, Hippocampus, Transgenic, Nerve Degeneration/genetics, Amyloid beta-Protein Precursor, Mice, Alzheimer Disease, SPA4CT, Animals, Transgenes, Peptide Fragments/genetics, Neurodegeneration, Alzheimer Disease/genetics, Amyloid beta-Peptides, Cell Death, Animal, Intraneuronal Aβ, Amyloid beta-Protein Precursor/metabolism, Immunohistochemistry, Peptide Fragments, Protein Structure, Tertiary, Presynaptic Terminals/metabolism, Disease Models, Animal, Gene Expression Regulation, Disease Models, Mutation, Nerve Degeneration, RC321-571
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 37 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
